NEUROMYELITIS OPTICA SPECTRUM DISORDERS

Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.

Never miss a new study

Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear

Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

Universal cell therapy trial aims to tame rogue immune system in devastating neurological diseases

Disease control Not yet recruiting

This early-phase study is testing a new 'off-the-shelf' cell therapy for people with severe neurological autoimmune diseases that have not responded to other treatments. Up to 15 participants with conditions like multiple sclerosis or myasthenia gravis will receive a single infus…

Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS

Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

NEUROMYELITIS OPTICA SPECTRUM DISORDERS

Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear

Universal cell therapy trial aims to tame rogue immune system in devastating neurological diseases